Testing New Models of Diabetes Self-Management to Improve Population Health
- Disease/Condition
- Diabetes Mellitus, Type 2
- Drug/Device/Intervention
- Living Healthier with Diabetes
- Study type
- Interventional
- Intervention type
- behavioral
- Primary sponsor
- Texas A&M University
- Location
- College Station, United States of America
- Phase
- N/A
- Start date
- Feb 01, 2019
- End date
- Mar 31, 2022
- Enrollment
- 191 participants
A1C -Change in HbA1c between baseline, 3 months, and 6 months is the primary outcome.
Aim 1.1 To understand if diabetes self-management education and support (DSMES) improves
 diabetes-related outcomes among those with Type 2 diabetes living in Texas.
 
 Aim 1.2 To examine how rurality affects study participation, engagement in, and effectiveness
 of different education interventions.
 
 These aims are based on a randomized controlled trial of different evidence-based diabetes
 self-management interventions.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06370494
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06370494 through Pure Global AI's free database. This phase not specified trial is sponsored by Texas A&M University and is currently Completed. The study focuses on Diabetes Mellitus, Type 2. Target enrollment is 191 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.